Damora Therapeutics Inc. Ordinary Shares (DMRA)
Stock · NASDAQ · Health Care
$29as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$24.44
Industry
Biotechnology: Pharmaceutical Preparations
Damora Therapeutics Inc. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- DMRADamora Therapeutics Inc. Ordinary Shares$29▼ 5.23%Market cap $1.76BP/E —
- LKFTLakefront Biotherapeutics American Depositary Shares$28.86▼ 1.97%Market cap $1.76BP/E 3.29$22.32$27.12
- ANIPANI Pharmaceuticals Inc.$72.83▼ 0.93%Market cap $1.80BP/E 18.72$70.15$99.5
- SNDXSyndax Pharmaceuticals Inc. Common Stock$19.55▼ 3.05%Market cap $1.70BP/E —$12.99$25.59
- BCAXBicara Therapeutics Inc. Common Stock$23.42▼ 5.70%Market cap $1.69BP/E —$10.3$30.99
- GENBGenerate Biomedicines Inc. Common Stock$15.33▼ 2.79%Market cap $1.84BP/E —$11$22.67
- OCULOcular Therapeutix Inc. Common Stock$10.36▼ 4.25%Market cap $1.84BP/E —$6.23$16.44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DMRA Damora Therapeutics Inc. Ordinary Shares | $1.76B | — | $29 | ▼ 5.23% | |
| LKFT Lakefront Biotherapeutics American Depositary Shares | $1.76B | 3.29 | $28.86 | ▼ 1.97% | $22.32$27.12 |
| ANIP ANI Pharmaceuticals Inc. | $1.80B | 18.72 | $72.83 | ▼ 0.93% | $70.15$99.5 |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | $1.70B | — | $19.55 | ▼ 3.05% | $12.99$25.59 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.69B | — | $23.42 | ▼ 5.70% | $10.3$30.99 |
| GENB Generate Biomedicines Inc. Common Stock | $1.84B | — | $15.33 | ▼ 2.79% | $11$22.67 |
| OCUL Ocular Therapeutix Inc. Common Stock | $1.84B | — | $10.36 | ▼ 4.25% | $6.23$16.44 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.